Lattice Therapeutics aims to unlock gene and nucleic acid therapy’s transformative potential for medicine to both cure and prevent diseases.
Lattice Therapeutics has raised $300K in total funding. The most recent round was Seed. The last funding was announced in June 2022.
Lattice Therapeutics is headquartered in Washington, United States.
Lattice Therapeutics aims to unlock gene and nucleic acid therapy’s transformative potential for medicine to both cure and prevent diseases.
Lattice Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lattice Therapeutics — Funding & Investors." VCBacked, June 13, 2022, https://www.vcbacked.co/company/lattice-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Lattice Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/lattice-therapeutics
{{cite web |title=Lattice Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lattice-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated